The CSF levels of all three investigated tryptic peptides of SNAP-25 were significantly higher in patients with prodromal Alzheimer’s disease and overt Alzheimer’s disease compared with non-demented controls (Figure 3A-C). The gene discussed is SNAP25; the disease is early-onset autosomal dominant Alzheimer disease.